tirzepatide injections naperville (Mounjaro) In Sherman Oaks Tirzepatide Injections & Treatment |
Description
Some are obvious
Tirzepatide (SURPASS trials): Weight reduction: 1521% depending on dose (515mg/week) Approved for type 2 diabetes Tolerability: mild to moderate GI effects Retatrutide (Phase 2 data): Weight reduction: 1724.2% across 1236 week protocols (515mg/week) Investigational
NexLife offers compounded tirzepatide starting at $215/month with no hidden fees
This does not necessarily mean that tirzepatide will be the best option for everyone, as both drugs are effectiveand different people respond differently to each drug
